Yes - biotech crops undergo more testing and oversight before commercialization than any other agricultural products, including conventional (or non-biotech) crops. In the U.S., every biotechnology product has to be submitted to two or more of the following agencies for approval: FDA (Food and Drug Administration), U.S. Department of Agriculture, and the EPA (Environmental Protection Agency).
Learn about the Regulatory Approval Process and safety testing our products go through.
What is Biotechnology?
Biotechnology, or genetic engineering, is the process of inserting a gene from one species, like a plant or a bacterium, into another species. Typically the gene inserted will express an advantageous characteristic in the plant, such as the ability to tolerate environmental pressures, like insect resistance or drought tolerance. At Monsanto our biotechnology work is concentrated on but not limited to corn, cotton, soybeans and canola.
Why does Monsanto use biotechnology?
At Monsanto, we use biotechnology to give plants desirable characteristics (or traits) that often cannot be developed through breeding practices. The traits we develop help farmers produce more of their crop and conserve resources. Examples of these traits would be herbicide tolerance, insect-resistance, drought-tolerance. We also are working to develop traits that will benefit consumers, such as soybeans that produce healthier oils.
Often, biotechnology is used to combine multiple traits in one seed. In the industry, this combination of traits is referred to as stacking.
Through the use of plant biotechnology our products are able to offer numerous benefits to the environment, farmers, and consumers. You can learn more about the products we’re developing by visiting our research and development pipeline.